Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 645 of 1,261
  1. US 9593163

    Oncostatin M receptor antigen binding proteins

    Kiniksa Pharmaceuticals, GmbH · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  2. US 9593162

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  3. US 9592304

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  4. US 9592265

    Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape seed extract

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  5. US 9593145

    Secondary structure stabilized NMDA receptor modulators and uses thereof

    Northwestern University · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  6. US 9592227

    Compositions of a polyorthoester and an aprotic solvent

    Heron Therapeutics, Inc. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  7. US 9592207

    Intranasal administration of ketamine to treat depression

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  8. US 9586937

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  9. US 9586975

    Macrocyclic salt-inducible kinase inhibitors

    Oncodesign SA · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  10. US 9587020

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  11. US 9587282

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  12. US 9586930

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  13. US 9585863

    Treatment of cataplexy

    Jazz Pharmaceuticals International III Limited · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  14. US 9588124

    Shape tunable plasmonic nanoparticles

    The Regents of the University of California · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  15. US 9586890

    Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods

    Northwestern University · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  16. US 9585928

    Agave syrup extract having anticancer activity

    INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  17. US 9585975

    MRI contrast agents

    Northwestern University · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  18. US 9587071

    Conjugated gold nanoparticles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  19. US 9586955

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  20. US 9586925

    1-(dimethylamino)ethyl-substituted 6H-benzo[C]chromen-6-ones against senile dementia

    NOBEL ILAÇ SANAYII VE TICARET A.S. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  21. US 9585558

    Hyperspectral imaging for early detection of Alzheimer'S Disease

    Regents of the University of Minnesota · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  22. US 9586908

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  23. US 9585921

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted
  24. US 9585941

    Eye drop formulation

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 7, 2017 · Expires Mar 2, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.